84 Épisodes

  1. Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes

    Publié: 10/01/2025
  2. Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures

    Publié: 12/12/2024
  3. Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis

    Publié: 06/11/2024
  4. Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease

    Publié: 01/11/2024
  5. Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer

    Publié: 31/07/2024
  6. Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy

    Publié: 01/07/2024
  7. Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS

    Publié: 17/05/2024
  8. Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease

    Publié: 07/05/2024
  9. Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa

    Publié: 22/04/2024
  10. Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake

    Publié: 12/03/2024
  11. Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity

    Publié: 01/03/2024
  12. Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region

    Publié: 19/12/2023
  13. Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy

    Publié: 29/11/2023
  14. Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease

    Publié: 12/10/2023
  15. Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction

    Publié: 13/09/2023
  16. Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis

    Publié: 10/08/2023
  17. Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease

    Publié: 12/07/2023
  18. Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis

    Publié: 07/06/2023
  19. Adelina Artenie on the incidence of HIV and HCV in people who inject drugs

    Publié: 10/05/2023
  20. Johan Burisch on the costs of inflammatory bowel disease in high-income settings

    Publié: 12/04/2023

1 / 5

Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.

Visit the podcast's native language site